Bristol-Myers Squibb Company (BMY) Moves Higher Ahead of ASCO Presscast / Abstracts

May 15, 2013 10:53 AM EDT
Get Alerts BMY Hot Sheet
Price: $56.28 --0%

Rating Summary:
    11 Buy, 11 Hold, 5 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 10 | Down: 16 | New: 50
Trade BMY Now!
Join SI Premium – FREE
Shares of Bristol-Myers Squibb Company (NYSE: BMY) moved higher early on Wednesday. Abstracts for American Society of Clinical Oncology (ASCO) annual meeting are due to be released today at 6 pm, ahead of the meeting which begins on May 31st.

Commenting, Leerink Swann analyst Seamus Fernandez said, "It was announced on April 29 that BMY's abstract on IO combination therapy with nivolumab & Yervoy (ipilimumab) in melanoma was selected for the annual meeting "presscast",
which occurs at noon on May 15."

"As we approach the annual meeting of the American Society of Clinical Oncology (Friday, May 31, to Tuesday, June 4, 2013), the enthusiasm of BMY's management team for immuno-oncology's long-term prospects continues unabated."

Leerink Swann has a Market Perform rating on Bristol-Myers Squibb Co. with a price target of $41-$42.

For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. (NYSE: BMY) click here. For more ratings news on Bristol-Myers Squibb Co. click here.

Shares of Bristol-Myers Squibb Co. closed at $42.21 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change, Trader Talk

Add Your Comment